FECAL CALPROTECTIN IS AN EARLY PREDICTOR OF ENDOSCOPIC RESPONSE AND HISTOLOGICAL REMISSION AFTER THE START OF VEDOLIZUMAB

被引：0
|
作者：
Pauwels, Renske W.
de Vries, Annemarie C.
Goet, Jorn
Erler, Nicole S.
Van der Woude, Christien Janneke
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
537
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [1] Faecal calprotectin is an early predictor of endoscopic response and histological remission after the start of vedolizumab
    Pauwels, R. W. M.
    de Vries, A. C.
    Goet, J. C.
    Erler, N. S.
    van der Woude, C. J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S285 - S286
  • [2] Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
    Pauwels, Renske W. M.
    van der Woude, Christien J.
    Erler, Nicole S.
    de Vries, Annemarie C.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [3] Fecal calprotectin as a predictor of histological remission in patients with ulcerative colitis treated with vedolizumab: A retrospective cohort study
    Rubtsov, D.
    Ramaswamy, P. Kakkadasam
    Mohsen, W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 104 - 104
  • [4] Fecal calprotectin is the most important predictor of endoscopic remission
    Wang, H.
    Neeman, T.
    Subramaniam, K.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 113 - 114
  • [5] Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis
    Wing Yan Mak
    Anthony Buisson
    Michael J. Andersen
    Donald Lei
    Joel Pekow
    Russell D. Cohen
    Stacy A. Kahn
    Bruno Pereira
    David T. Rubin
    [J]. Digestive Diseases and Sciences, 2018, 63 : 1294 - 1301
  • [6] Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis
    Mak, Wing Yan
    Buisson, Anthony
    Andersen, Michael J., Jr.
    Lei, Donald
    Pekow, Joel
    Cohen, Russell D.
    Kahn, Stacy A.
    Pereira, Bruno
    Rubin, David T.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (05) : 1294 - 1301
  • [7] Calprotectin at week 12 is a predictor for histological remission in ulcerative colitis patients treated with Vedolizumab
    Rubstov, D.
    Ramaswamy, P. Kakkadasam
    Edwards, J.
    Shukla, D.
    Willmann, L.
    Moattar, H.
    Bhullar, M.
    Ishaq, N.
    Dorrington, A.
    Mohsen, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S515 - S516
  • [8] Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice
    Pauwels, Renske Wilhelmina Maria
    de Vries, Annemarie Charlotte
    van der Woude, Christien Janneke
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (11) : 1893 - 1901
  • [9] Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission
    Kawashima, Kousaku
    Oshima, Naoki
    Kishimoto, Kenichi
    Kataoka, Masatoshi
    Fukunaga, Mai
    Kotani, Satoshi
    Sonoyama, Hiroki
    Oka, Akihiko
    Mishima, Yoshiyuki
    Kazumori, Hideaki
    Ishikawa, Noriyoshi
    Araki, Asuka
    Ishihara, Shunji
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 (03) : 359 - 366
  • [10] Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients
    Cannatelli, Rosanna
    Bazarova, Alina
    Zardo, Davide
    Nardone, Olga Maria
    Shivaji, Uday
    Smith, Samuel Charles Lloyd
    Gkoutos, Georgios
    Ricci, Chiara
    Gui, Xianyong Sean
    Ghosh, Subrata
    Iacucci, Marietta
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (05) : 647 - 654
12345